These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21467790)
1. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation]. Ishiguro M; Hara H Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790 [TBL] [Abstract][Full Text] [Related]
2. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage. Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431 [TBL] [Abstract][Full Text] [Related]
3. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury. Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW CNS Neurosci Ther; 2008; 14(2):143-52. PubMed ID: 18482026 [TBL] [Abstract][Full Text] [Related]
5. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318 [TBL] [Abstract][Full Text] [Related]
6. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial. Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T; Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice. Kitashoji A; Egashira Y; Mishiro K; Suzuki Y; Ito H; Tsuruma K; Shimazawa M; Hara H Stroke; 2013 Oct; 44(10):2862-8. PubMed ID: 23881959 [TBL] [Abstract][Full Text] [Related]
8. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161 [TBL] [Abstract][Full Text] [Related]
9. Cilostazol: therapeutic potential against focal cerebral ischemic damage. Hong KW; Lee JH; Kima KY; Park SY; Lee WS Curr Pharm Des; 2006; 12(5):565-73. PubMed ID: 16472148 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. Choi JM; Shin HK; Kim KY; Lee JH; Hong KW J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782 [TBL] [Abstract][Full Text] [Related]
11. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier. Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252 [TBL] [Abstract][Full Text] [Related]
12. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke. Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175 [TBL] [Abstract][Full Text] [Related]
13. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: protective effects of antiplatelet agents against stroke. Shimazawa M; Hara H J Pharmacol Sci; 2011; 116(1):30-5. PubMed ID: 21498958 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives. Takagi T; Hara H J Pharmacol Sci; 2016 Jul; 131(3):155-61. PubMed ID: 27381422 [TBL] [Abstract][Full Text] [Related]
15. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial. Hong KS; Kim BJ; Lee JY; Kwon SU; Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566 [TBL] [Abstract][Full Text] [Related]
17. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells. Sanada F; Kanbara Y; Taniyama Y; Otsu R; Carracedo M; Ikeda-Iwabu Y; Muratsu J; Sugimoto K; Yamamoto K; Rakugi H; Morishita R Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia. Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S Brain Res; 2015 Mar; 1602():53-61. PubMed ID: 25617822 [TBL] [Abstract][Full Text] [Related]
19. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats. Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620 [TBL] [Abstract][Full Text] [Related]
20. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia. Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]